Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia

Psychopharmacology

Volumn 199, Issue 1, 2008, Pages 89-98

  Jubelt, Lindsay E ^a   Barr, Ruth S ^a,b   Goff, Donald C ^a,b   Logvinenko, Tanya ^a,b   Weiss, Anthony P ^a,b   Evins, A Eden ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Acetylcholine; False alarm; Impulsivity; Inhibitory control; Memory; Nicotine; Novelty detection; Schizophrenia

Indexed keywords

NICOTINE; PLACEBO;

ACCURACY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISODIC MEMORY; FEMALE; FUNCTIONAL DISEASE; HUMAN; MALE; NOVELTY DETECTION; POSITIVE SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOGNITION; RESPONSE TIME; SCHIZOPHRENIA; SINGLE DRUG DOSE; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ADULT; AROUSAL; ATTENTION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NICOTINE; PSYCHOTIC DISORDERS; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VERBAL LEARNING;

EID: 46149097142     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1133-8     Document Type: Article

References (81)

1. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R (1992) Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry 32:607-616
2. Adler LE, Hoffer LD, Wiser A, Freedman R (1993) Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150:1856-1861
3. Albuquerque EX, Pereira EF, Braga MF, Alkondon M (1998) Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of alpha 7 receptors. J Physiol Paris 92:309-316
4. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV). American Psychiatric Association, Washington, DC, USA
5. Arendash GW, Sanberg PR, Sengstock GJ (1995) Nicotine enhances the learning and memory of aged rats. Pharmacol Biochem Behav 52:517-523
6. Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE (2008) The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology 33:480-490
7. Benowitz NL (1995) Clinical pharmacology of transdermal nicotine. Eur J Pharm Biopharm 41:168-174
8. Brebion G, Smith MJ, Gorman JM, Amador X (1997) Discrimination accuracy and decision biases in different types of reality monitoring in schizophrenia. J Nerv Ment Dis 185:247-253
9. Brebion G, Smith MJ, Amador X, Malaspina D, Gorman JM (1998) Word recognition, discrimination accuracy, and decision bias in schizophrenia: association with positive symptomatology and depressive symptomatology. J Nerv Ment Dis 186:604-609
10. Brebion G, Amador X, Smith M, Malaspina D, Sharif Z, Gorman JM (2000) Depression, psychomotor retardation, negative symptoms, and memory in schizophrenia. Neuropsychiatry Neuropsychol Behav Neurol 13:177-183
11. Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM, Marks MJ, Collins AC, Leonard S (2000) Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 23:351-364
12. Brown MW, Bashir ZI (2002) Evidence concerning how neurons of the perirhinal cortex may effect familiarity discrimination. Philos Trans R Soc Lond B Biol Sci 357:1083-1095
13. Ciamei A, Aversano M, Cestari V, Castellano C (2001) Effects of MK-801 and nicotine combinations on memory consolidation in CD1 mice. Psychopharmacology (Berl) 154:126-130
14. Cirillo MA, Seidman LJ (2003) Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev 13:43-77
15. Craik FI, Govoni R, Naveh-Benjamin M, Anderson ND (1996) The effects of divided attention on encoding and retrieval processes in human memory. J Exp Psychol Gen 125:159-180
16. de Leon J, Diaz FJ (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76:135-157
17. de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM (1995) Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 152:453-455
18. Depatie L, O'Driscoll GA, Holahan AL, Atkinson V, Thavundayil JX, Kin NN, Lal S (2002) Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology 27:1056-1070
19. Duncan E, Madonick S, Chakravorty S, Parwani A, Szilagyi S, Efferen T, Gonzenbach S, Angrist B, Rotrosen J (2001) Effects of smoking on acoustic startle and prepulse inhibition in humans. Psychopharmacology (Berl) 156:266-272
20. Durany N, Zochling R, Boissl KW, Paulus W, Ransmayr G, Tatschner T, Danielczyk W, Jellinger K, Deckert J, Riederer P (2000) Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome. Neurosci Lett 287:109-112
21. Ernst M, Heishman SJ, Spurgeon L, London ED (2001) Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology 25:313-319
22. Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC (2005) Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. J Clin Psychiatry 66:1184-1190
23. Franck N, Rouby P, Daprati E, Dalery J, Marie-Cardine M, Georgieff N (2000) Confusion between silent and overt reading in schizophrenia. Schizophr Res 41:357-364
24. Freedman R, Hall M, Adler LE, Leonard S (1995) Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38:22-33
25. George TP, Vessicchio JC, Termine A, Sahady DM, Head CA, Pepper WT, Kosten TR, Wexler BE (2002) Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 26:75-85
26. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-330
27. Gupta SK, Okerholm RA, Coen P, Prather RD, Gorsline J (1993) Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System). J Clin Pharmacol 33:168-174
28. Hajos M, Hurst RS, Hoffmann WE, Krause M, Wall TM, Higdon NR, Groppi VE (2005) The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats. J Pharmacol Exp Ther 312:1213-1222
29. Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B, Zerbe G, Freedman R (2004) Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29:1378-1385
30. Hasselmo ME, Giocomo LM (2006) Cholinergic modulation of cortical function. J Mol Neurosci 30:133-135
31. Hoff AL, Kremen WS, Wieneke MH, Lauriello J, Blankfeld HM, Faustman WO, Csernansky JG, Nordahl TE (2001) Association of estrogen levels with neuropsychological performance in women with schizophrenia. Am J Psychiatry 158:1134-1139
32. Hughes J (1986) Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143:993-997
33. Ishigaki T, Tanno Y (1999) The signal detection ability of patients with auditory hallucination: analysis using the continuous performance test. Psychiatry Clin Neurosci 53:471-476
34. Jacobsen LK, D'Souza DC, Mencl WE, Pugh KR, Skudlarski P, Krystal JH (2004) Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry 55:850-858
35. Janhunen S, Ahtee L (2007) Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development. Neurosci Biobehav Rev 31:287-314
36. Ji D, Dani JA (2000) Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons. J Neurophysiol 83:2682-2690
37. Keefe RS, Arnold MC, Bayen UJ, Harvey PD (1999) Source monitoring deficits in patients with schizophrenia; a multinomial modelling analysis. Psychol Med 29:903-914
38. Kelly C, McCreadie RG (1999) Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry 156:1751-1757
39. Kiba H, Jayaraman A (1994) Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation. Brain Res Mol Brain Res 23:1-13
40. Kumaran D, Maguire EA (2007) Match mismatch processes underlie human hippocampal responses to associative novelty. J Neurosci 27:8517-8524
41. Kumari V, Soni W, Sharma T (2001) Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum Psychopharmacol 16:321-326
42. Lambe EK, Picciotto MR, Aghajanian GK (2003) Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28:216-225
43. Laruelle M, Kegeles LS, Abi-Dargham A (2003) Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci 1003:138-158
44. Lawrence NS, Ross TJ, Stein EA (2002) Cognitive mechanisms of nicotine on visual attention. Neuron 36:539-548
45. Levin ED, Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 138:217-230
46. Levin ED, Rezvani AH (2002) Nicotinic treatment for cognitive dysfunction. Curr Drug Target CNS Neurol Disord 1:423-431
47. Levin ED, Conners CK, Silva D, Hinton SC, Meck WH, March J, Rose JE (1998) Transdermal nicotine effects on attention. Psychopharmacology (Berl) 140:135-141
48. Levin ED, McClernon FJ, Rezvani AH (2006) Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184:523-539
49. Macmillan N, Creelman C (1991) Detection theory: a user's guide. Cambridge University Press, Cambridge
50. Mancuso G, Andres P, Ansseau M, Tirelli E (1999) Effects of nicotine administered via a transdermal delivery system on vigilance: a repeated measure study. Psychopharmacology (Berl) 142:18-23
51. Mansvelder HD, McGehee DS (2000) Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27:349-357
52. McClernon FJ, Gilbert DG, Radtke R (2003) Effects of transdermal nicotine on lateralized identification and memory interference. Hum Psychopharmacol 18:339-343
53. McClernon FJ, Hiott FB, Westman EC, Rose JE, Levin ED (2006) Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. Psychopharmacology (Berl) 189:125-133
54. Mexal S, Frank M, Berger R, Adams CE, Ross RG, Freedman R, Leonard S (2005) Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res 139:317-332
55. Myers CS, Robles O, Kakoyannis AN, Sherr JD, Avila MT, Blaxton TA, Thaker GK (2004) Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology (Berl) 174:334-340
56. Naveh-Benjamin M, Craik FI, Gavrilescu D, Anderson ND (2000) Asymmetry between encoding and retrieval processes: evidence from divided attention and a calibration analysis. Mem Cognit 28:965-976
57. Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, Craft S, Olney JW (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20:106-118
58. Nomikos GG, Schilstrom B, Hildebrand BE, Panagis G, Grenhoff J, Svensson TH (2000) Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. Behav Brain Res 113:97-103
59. Olincy A, Young DA, Freedman R (1997) Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry 42:1-5
60. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007
61. Perry EK, Court JA, Johnson M, Smith CJ, James V, Cheng AV, Kerwin JM, Morris CM, Piggott MA, Edwardson JA et al (1993) Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus. Hippocampus 3:307-315
62. Poltavski DV, Petros T (2006) Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits. Physiol Behav 87:614-624
63. Postma P, Gray JA, Sharma T, Geyer M, Mehrotra R, Das M, Zachariah E, Hines M, Williams SC, Kumari V (2006) A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology (Berl) 184:589-599
64. Ranganath C, Rainer G (2003) Neural mechanisms for detecting and remembering novel events. Nat Rev Neurosci 4:193-202
65. Rezvani AH, Kholdebarin E, Dawson E, Levin ED (2007) Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats. Int J Neuropsychopharmacol:1-8
66. Rusted JM, Graupner L, Tennant A, Warburton DM (1998) Effortful processing is a requirement for nicotine-induced improvements in memory. Psychopharmacology (Berl) 138:362-368
67. Rusted JM, Trawley S, Heath J, Kettle G, Walker H (2005) Nicotine improves memory for delayed intentions. Psychopharmacology (Berl) 182:355-365
68. Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62:649-659
69. Sherr JD, Myers C, Avila MT, Elliott A, Blaxton TA, Thaker GK (2002) The effects of nicotine on specific eye tracking measures in schizophrenia. Biol Psychiatry 52:721-728
70. Smith RC, Warner-Cohen J, Matute M, Butler E, Kelly E, Vaidhyanathaswamy S, Khan A (2006) Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology 31:637-643
71. Snodgrass JG, Corwin J (1988) Pragmatics of measuring recognition memory: applications to dementia and amnesia. J Exp Psychol Gen 117:34-50
72. Strand JE, Nyback H (2005) Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. Eur Psychiatry 20:50-54
73. Sziraki I, Sershen H, Benuck M, Hashim A, Lajtha A (1998) Receptor systems participating in nicotine-specific effects. Neurochem Int 33:445-457
74. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM (2005) Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend 80:259-265
75. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR (2007) Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull 33:69-94
76. Weiss A, Goff D, Duff M, Roffman J, Schacter D (2008) Distinguishing familiarity-based from source-based memory in patients with schizophrenia. Schizophr Res 99(1-3):208-217
77. White HK, Levin ED (2004) Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. Psychopharmacology (Berl) 171:465-671
78. Wilding EL (1999) Separating retrieval strategies from retrieval success: an event-related potential study of source memory. Neuropsychologia 37:441-454
79. Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL (2005) Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res 79:323-335
80. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten JR (1995) Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-514
81. Zhang X, Tan Y, Zhou D, Haile C, Wu G, Cao L (2007) Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia. Neuropsychopharmacology 32(9):2020-2024